Study of a long-acting injectable in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests a new long-acting injectable medication (S-892216 LAI) in healthy adults. It helps researchers understand how the drug works in the body when given as a shot, which could lead to a treatment given less often in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a generally healthy adult volunteer.
- Your body mass index (BMI) must be between 18.5 and 32.0.
- You cannot have any major health conditions like heart disease, lung disease, liver or kidney problems, or diabetes.
- You cannot have had cancer (except for certain skin cancers removed more than 3 years ago).
- You cannot be taking any prescription or over-the-counter medications or require other treatments.
- You cannot have used cannabis, tobacco, or nicotine products in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests a new injectable medication (SYH2082) that works like GLP-1 and GIP drugs to see how safe it is and how your body handles it. You must be healthy with no diabetes, thyroid cancer risk, or recent major surgery.
This study tests a new medicine called LAE102 in two groups: healthy volunteers and people who are overweight or obese. The goal is to see if it is safe and how the body processes it.
This trial is testing a new drug called LAE103 (and LAE102) in healthy people who are overweight or obese. It aims to see if the drug is safe and how the body processes it.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.